Inaspir Accuhaler (Salmeterol)

Salmeterol selectively stimulates β2‑adrenergic receptors on bronchial smooth‑muscle cells, activating adenylate cyclase and raising cyclic AMP levels. The increased cAMP causes smooth‑muscle relaxation, leading to prolonged bronchodilation that can last up to 12 hours after each inhalation.

The prescribed dose of Inaspir Accuhaler is determined by the treating physician based on the individual’s disease severity, age and response to therapy. The prescriber decides the number of inhalations per day and the timing of each dose.

The safety of Salmeterol in pregnancy and lactation has not been definitively established. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Inaspir Accuhaler delivers Salmeterol via a dry‑powder inhaler, offering a consistent dose of 50 µg per inhalation and a duration of action of up to 12 hours. Compared with other LABAs such as formoterol, Salmeterol has a slower onset but a similar duration, and the Accuhaler device may be preferred by patients who find dry‑powder inhalers easier to use.

The inhaler should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the device out of reach of children and avoid exposing it to extreme heat or humidity.

The patient inhales a single dose by placing the Accuhaler in the mouth, sealing the lips around the mouthpiece, and breathing in forcefully and deeply. After inhalation, the patient should hold their breath for about 10 seconds to allow optimal drug deposition, then exhale slowly.

Serious adverse events include paradoxical bronchospasm, severe allergic reactions such as anaphylaxis, cardiac arrhythmias, and significant drops in blood potassium (hypokalemia). Patients should seek immediate medical attention if they experience sudden worsening of breathing, chest pain, palpitations or signs of an allergic reaction.

Inaspir Accuhaler is contraindicated in patients with a known hypersensitivity to Salmeterol or any component of the inhaler, and it should be avoided in individuals who require a rapid‑acting bronchodilator for acute symptom relief. Caution is also advised for patients with severe cardiovascular disorders.